DNA Damage-Mediated Induction of a Chemoresistant Niche

Gilbert, Luke A., Hemann, Michael T.·2010·Cell

DOI 10.1016/j.cell.2010.09.043

Cited by (428)

Items 201–300 of 428

Discovery and Characterization of a Novel Aryl Hydrocarbon Receptor Inhibitor, IK-175, and Its Inhibitory Activity on Tumor Immune Suppression
Karen McGovern, Alfredo C. Castro, Jill Cavanaugh, Sílvia Coma, Meghan Walsh, Jeremy H. Tchaicha, Sakeena Syed, Prabitha Natarajan, Mark G Manfredi, Xiaoyan M. Zhang et al. · 2022 · Molecular Cancer Therapeutics
The pharmacological point of view of resistance to therapy in tumors
Giovanna L.M. Damia, Silvio K. Garattini · 2014 · Cancer Treatment Reviews
Regulation of IL-6 signaling by miR-125a and let-7e in endothelial cells controls vasculogenic mimicry formation of breast cancer cells
Youngsook Park, Jongmin Kim · 2019 · BMB Reports
Host effects contributing to cancer therapy resistance.
Katz, Ofrat Beyar, Shaked, Yuval · 2015 · Drug Resistance Updates
Extracellular vesicles in the tumor microenvironment: Therapeutic resistance, clinical biomarkers, and targeting strategies
Lu Han, Jiaqian Xu, Qing Rong Xu, B. Zhang, Eric W.‐F. Lam, Yu Sun · 2017 · Medicinal Research Reviews
Emerging targets in cancer drug resistance
Shashank Kumar, Prem Prakash Kushwaha, Sanjay Gupta · 2019 · Cancer Drug Resistance
The tumor microenvironment: a key player in multidrug resistance in cancer
Lingnan Meng, Ying Zheng, Hao Liu, Daiming Fan · 2024 · ONCOLOGIE
Chemotherapy induces tumor immune evasion by upregulation of programmed cell death ligand 1 expression in bone marrow stromal cells
Mengqi Yang, Panpan Liu, Kefeng Wang, Christophe Glorieux, Yumin Hu, Shijun Wen, Wenqi Jiang, Peng Huang · 2017 · Molecular Oncology
A Metabolomic Approach to Predict Breast Cancer Behavior and Chemotherapy Response
Marcella Regina Cardoso, Juliana Carvalho Santos, Marcelo Lima Ribeiro, Maria Talarico, Laís Rosa Viana, Sophie Derchain · 2018 · International Journal of Molecular Sciences
Biomarkers of Residual Disease, Disseminated Tumor Cells, and Metastases in the MMTV-PyMT Breast Cancer Model
Christian Franci, Jenny Zhou, Zhaoshi Jiang, Zora D. Modrusan, Zinaida Good, Erica L. Jackson, Hosein Kouros‐Mehr · 2013 · PLoS ONE
Beyond Tissue Stiffness and Bioadhesivity: Advanced Biomaterials to Model Tumor Microenvironments and Drug Resistance
Ankur K. Singh, Ilana Brito, Jan Lammerding · 2018 · Trends in cancer
The pan-therapeutic resistance of disseminated tumor cells: Role of phenotypic plasticity and the metastatic microenvironment
Bo Ma, Alan H. Wells, Amanda M. Clark · 2019 · Seminars in Cancer Biology
Preconditioning thermal therapy: Flipping the switch on IL-6 for anti-tumour immunity
Maryann E. Mikucki, Daniel T. Fisher, Amy W. Ku, Michelle M. Appenheimer, Jason B. Muhitch, Sharon S. Evans · 2013 · International Journal of Hyperthermia
Tumor-associated fibroblast-conditioned medium induces CDDP resistance in HNSCC cells
Teresa Bernadette Steinbichler, Veronika Maria Metzler, Christian Oliver Pritz, Herbert Riechelmann, József Dudás · 2015 · Oncotarget
Tumor‐stroma interactions differentially alter drug sensitivity based on the origin of stromal cells
Benjamin D. Landry, Thomas Leete, Ryan Richards, Peter Cruz‐Gordillo, Hannah R. Schwartz, Megan E. Honeywell, Gary Ren, Alyssa D. Schwartz, Shelly R. Peyton, Michael J. Lee · 2018 · Molecular Systems Biology
Topoisomerase inhibitors promote cancer cell motility via ROS-mediated activation of JAK2-STAT1-CXCL1 pathway
Jiafei Liu, Like Qu, Lin Meng, Chengchao Shou · 2019 · Journal of Experimental & Clinical Cancer Research
Effects of senescence on the tumour microenvironment and response to therapy
Louise E. Reynolds, Seynab Maallin, Scott Haston, Juan Pedro Martı́nez-Barberá, Kairbaan Hodivala‐Dilke, Ana‐Rita Pedrosa · 2023 · FEBS Journal
Predictive value of epithelial‐mesenchymal‐transition (EMT) signature and PARP‐1 in prostate cancer radioresistance
Timothy W. Stark, Patrick Joseph Hensley, Amanda Spear, Hong Pu, Stephen E. Strup, Natasha Kyprianou · 2017 · The Prostate
Blocking ATM-dependent NF-κB pathway overcomes niche protection and improves chemotherapy response in acute lymphoblastic leukemia
Yali Chen, Chao Shu Tang, Meng‐Yi Zhang, Wenli Huang, Yan Kang Xu, Hui-Yin Sun, Fan Yang, Lili Song, He Wang, Lili Mu et al. · 2019 · Leukemia
Dual blockage of STAT3 and ERK1/2 eliminates radioresistant GBM cells
Bowen Xie, Lu Zhang, Wenfeng Hu, Ming Fan, Nian Jiang, Yumei Duan, Di Jing, Wenwu Xiao, Ruben C. Fragoso, Kit S. Lam et al. · 2019 · Redox Biology
miRNA-1246 in extracellular vesicles secreted from metastatic tumor induces drug resistance in tumor endothelial cells
Chisaho Torii, Nako Maishi, Taisuke Kawamoto, Masahiro Morimoto, Kosuke Akiyama, Yusuke Yoshioka, Takashi Minami, Takuya Tsumita, Mohammad Towfik Alam, Takahiro Ochiya et al. · 2021 · Scientific Reports
Fibroblast CEBPD/SDF4 axis in response to chemotherapy-induced angiogenesis through CXCR4
Jhih-Ying Chi, Yu‐Wei Hsiao, Hai-Ling Liu, Xin-Juan Fan, Xiang‐Bo Wan, Tsung-Lin Liu, Sheng‐Jou Hung, Yi‐Ting Chen, Hsin-Yin Liang, Ju‐Ming Wang · 2021 · Cell Death Discovery
Treatment-induced host-mediated mechanisms reducing the efficacy of antitumor therapies
Laura G.M. Daenen, Julia M. Houthuijzen, Geert A. Cirkel, Jeanine M.L. Roodhart, Yuval Shaked, Emile E. Voest · 2013 · Oncogene
Tutorial: design and execution of CRISPR in vivo screens
Christian Joerg Braun, Andrés Carbonell Adames, Dieter Saur, Roland Rad · 2022 · Nature Protocols
Specific chemotherapeutic agents induce metastatic behaviour through stromal‐ and tumour‐derived cytokine and angiogenic factor signalling
Guanghua Liu, Yang Chen, Feifei Qi, Lin Jia, Xin‐an Lu, Ting He, Yan Fu, Lin Li, Yongzhang Luo · 2015 · The Journal of Pathology
Mesenchymal stem cells and carcinoma-associated fibroblasts sensitize breast cancer cells in 3D cultures to kinase inhibitors
Jï¿½rgen Dittmer · 2011 · International Journal of Oncology
Jab1/Cops5 contributes to chemoresistance in breast cancer by regulating Rad51
Guohong Liu, Mingxia Yu, Balu Wu, Shuang Guo, Xin Huang, Fuling Zhou, Francois Xavier Claret, Yunbao Pan · 2018 · Cellular Signalling
Importance of the origin of mesenchymal (stem) stromal cells in cancer biology: “alliance” or “war” in intercellular signals
Noemí Eiró, María Fraile, Silvia Fernández-Francos, Rosario Sánchez, Luis A. Costa, Francisco José Vizoso · 2021 · Cell & Bioscience
Integrative computational in-depth analysis of dysregulated miRNA-mRNA interactions in drug-resistant pediatric acute lymphoblastic leukemia cells: an attempt to obtain new potential gene-miRNA pathways involved in response to treatment
Hamzeh Mesrian Tanha, Marjan Mojtabavi Naeini, Soheila Rahgozar, Alireza Moafi, Mohammad Amin Honardoost · 2015 · Tumor Biology
Establishment of Structure-Function Relationship of Tissue Inhibitor of Metalloproteinase-1 for Its Interaction with CD63: Implication for Cancer Therapy
Richard B. Warner, Abdo J. Najy, Young Suk Jung, Rafael A. Fridman, Seongho Kim, Hyeong-Reh Choi Kim · 2020 · Scientific Reports
Context-specific roles for paracrine IL-6 in lymphomagenesis
Luke A. Gilbert, Michael T. Hemann · 2012 · Genes & Development
MiR-203 inhibits tumor invasion and metastasis in gastric cancer by ATM
Ping Zhou, Nan Jiang, Guoxia Zhang, Qing Sun · 2016 · Acta Biochimica et Biophysica Sinica
Role of telomerase in the tumour microenvironment
Ning Liu, Xuehua Guo, Junping Liu, Yu‐Sheng Cong · 2019 · Clinical and Experimental Pharmacology and Physiology
The Interplay between MicroRNAs and the Components of the Tumor Microenvironment in B-Cell Malignancies
Sherien M. El‐Daly, Recep Bayraktar, Simone Anfossi, George A. Călin · 2020 · International Journal of Molecular Sciences
PSMA-targeted arsenic nanosheets: a platform for prostate cancer therapy via ferroptosis and ATM deficiency-triggered chemosensitization
Hui Wang, Li Zhang, Zhaohua Miao, Meng Zhang, Hang Liu, Qiong He, Jialin Meng, Longping Wen, Zunfu Ke, Zhengbao Zha et al. · 2021 · Materials Horizons
Mouse tumour models to guide drug development and identify resistance mechanisms
Meghna Das Thakur, Nancy Pryer, Mallika Singh · 2013 · The Journal of Pathology
The B-cell receptor orchestrates environment-mediated lymphoma survival and drug resistance in B-cell malignancies
Kenneth H. Shain, Jianguo Tao · 2013 · Oncogene
Nanomedicine and chemotherapeutics drug delivery: challenges and opportunities
Sepideh Nezhadi, Ebrahim Saadat, Somayeh Handali, Farid Abedin Dorkoosh · 2020 · Journal of drug targeting
Suppression of Endothelial Cell FAK Expression Reduces Pancreatic Ductal Adenocarcinoma Metastasis after Gemcitabine Treatment
Marina Roy-Luzarraga, Louise E. Reynolds, Beatriz de Luxán‐Delgado, Óscar Maiques, Laura Wisniewski, Emma Newport, Vinothini Rajeeve, Rebecca J.G. Drake, Jesús Gómez-Escudero, Frances M. Richards et al. · 2022 · Cancer Research
Gemcitabine enhances cell invasion via activating HAb18G/CD147-EGFR-pSTAT3 signaling
Bao-Qing Xu, Zhiguang Fu, Yao Meng, Xiaoqing Wu, Bo Wu, Liang Xu, Jian‐Li Jiang, Ling Li, Zhi‐Nan Chen · 2016 · Oncotarget
ATM-Mediated DNA Damage Signals Mediate Immune Escape through Integrin-αvβ3–Dependent Mechanisms
Masahisa Jinushi, Shigeki Chiba, Muhammad Baghdadi, Ichiro Kinoshita, Hirotoshi Dosaka‐Akita, Koyu Ito, Hironori Yoshiyama, Hideo Yagita∥, Toshimitsu Uede, Akinori Takaoka · 2011 · Cancer Research
Bepotastine Sensitizes Ovarian Cancer to PARP Inhibitors through Suppressing NF-κB–Triggered SASP in Cancer-Associated Fibroblasts
Ping Jin, Xin Li, Yu Xia, Huayi Li, Xiaoting Li, Zongyuan Yang, Zhen Wang, Cheng Xu, Tian Fang, Dongchen Zhou et al. · 2023 · Molecular Cancer Therapeutics
Mesenchymal Stem/Stromal Cells May Decrease Success of Cancer Treatment by Inducing Resistance to Chemotherapy in Cancer Cells
Taja Železnik Ramuta, Mateja Erdani Kreft · 2022 · Cancers
Understanding cellular senescence: pathways involved, therapeutics and longevity aiding
Ashish Kumar, Kavitha Thirumurugan · 2023 · Cell Cycle
MLK4 regulates DNA damage response and promotes triple-negative breast cancer chemoresistance
Dawid Mehlich, Michał Łomiak, Aleksandra Sobiborowicz, Alicja Mazan, Dagmara Dymerska, Łukasz Mateusz Szewczyk, Anna Mehlich, Agnieszka Borowiec, Monika K. Prełowska, Adam Gorczyński et al. · 2021 · Cell Death and Disease
Senotherapies: A novel strategy for synergistic anti-tumor therapy
Xuxin Qi, Jiang Li, Ji Cao · 2022 · Drug Discovery Today
Determinants of outcome following PSMA-based radioligand therapy and mechanisms of resistance in patients with metastatic castration-resistant prostate cancer
Louise Kathleen Kostos, James Patrick Buteau, Michael S. Hofman, Arun Azad · 2023 · Therapeutic Advances in Medical Oncology
Concise Review: The Malignant Hematopoietic Stem Cell Niche
Juo-Chin Yao, Daniel C. Link · 2016 · Stem Cells
Phylostratigraphic analysis of tumor and developmental transcriptomes reveals relationship between oncogenesis, phylogenesis and ontogenesis
Joseph Zhou, Luis Humberto Cisneros, Theo Knijnenburg, Kalliopi Trachana, P. C. W. Davies, Sui Huang · 2018 · Convergent Science Physical Oncology
Long noncoding RNA lnc-LOC645166 promotes adriamycin resistance via NF-κB/GATA3 axis in breast cancer
Ruinian Zheng, Jun Jia, Ling Guan, Huiling Yuan, Kejun Liu, Chun Liu, Weibiao Ye, Yu‐Ting Amber Liao, Shunhuan Lin, Ou Huang · 2020 · Aging
The host immunological response to cancer therapy: An emerging concept in tumor biology
Tali Voloshin, Emile E. Voest, Yuval Shaked · 2013 · Experimental Cell Research
Tumors as chaotic attractors
Svetoslav Ganchev Nikolov, Olaf Wolkenhauer A, Julio Vera · 2013 · Molecular BioSystems
Chronic inflammation decreases HSC fitness by activating the druggable Jak/Stat3 signaling pathway
Srdjan Grusanovic, Petr Daněk, Maria Kuzmina, Miroslava Kari Adamcova, Monika Burócziová, Romana Mikyšková, Karolina Vanickova, Sladjana Kosanovic, Jana Pokorna, Milan Reiniš et al. · 2022 · EMBO Reports
Senescent cells: A new Achilles’ heel to exploit for cancer medicine?
Boyi Zhang, Eric W.‐F. Lam, Yu Sun · 2018 · Aging Cell
TIMP-1-Mediated Chemoresistance via Induction of IL-6 in NSCLC
Wei Lie Xiao, Lan Wang, John Harrison Howard, Ravindra B Kolhe, Amyn M. Rojiani, Mumtaz V. Rojiani · 2019 · Cancers
Fluorescence‐based experimental model to evaluate the concomitant effect of drugs on the tumour microenvironment and cancer cells
Karthik Ramasamy, Hazera Khatun, Lee Macpherson, Mathew P. Caley, Justin Sturge, Ghulam Jeelani Mufti, Stephen Schey, Yolanda Calle · 2012 · British Journal of Haematology
Aiding and Abetting: How the Tumor Microenvironment Protects Cancer from Chemotherapy
Eleanor C. Fiedler, Michael T. Hemann · 2018 · Annual Review of Cancer Biology
Elevated circulating tissue inhibitor of metalloproteinase 1 (TIMP‐1) levels are associated with neuroendocrine differentiation in castration resistant prostate cancer
Yixuan Gong, Uma Chippada-Venkata, Matthew D. Galsky, Jiaoti Huang, William K. Oh · 2015 · The Prostate
Progression-related loss of stromal Caveolin 1 levels fosters the growth of human PC3 xenografts and mediates radiation resistance
Andrej Panic, Julia Ketteler, Henning Reis, Ali Sak, Carsten Herskind, Patrick Maier, Herbert Rubben, Verena Jendrossek, Diana Klein · 2017 · Scientific Reports
Pulsed-Focused Ultrasound Slows B16 Melanoma and 4T1 Breast Tumor Growth through Differential Tumor Microenvironmental Changes
Gadi Cohen, Parwathy Chandran, Rebecca M. Lorsung, Ömer Faruk Aydin, Lauren E. Tomlinson, Robert B. Rosenblatt, Scott Robert Burks, Joseph Alan Frank · 2021 · Cancers
Oligonucleotide Therapeutics in Cancer
Jing Wan, John A. Bauman, Maria A Graziewicz, Peter Sazani, Ryszard Kole · 2013 · Cancer treatment and research
Accelerating Cancer Modeling with RNAi and Nongermline Genetically Engineered Mouse Models
Geulah Livshits, Scott W. Lowe · 2013 · Cold Spring Harbor Protocols
Clearance of senescent hepatocytes in a neoplastic-prone microenvironment delays the emergence of hepatocellular carcinoma
Fabio Marongiu, Maria Paola Serra, Marcella Sini, Fabrizio Angius, Ezio Laconi · 2014 · Aging
Tumor suppressor p53 mediates interleukin-6 expression to enable cancer cell evasion of genotoxic stress
Trinh T. T. Phan, Nam V. Truong, Wen‐guey Wu, Yi-Chun Su, Tzu-Sheng Hsu, Lih‐Yuan Lin · 2023 · Cell Death Discovery
The impact of the senescent microenvironment on tumorigenesis: Insights for cancer therapy
Wenqiang Zhang, Kexin Zhang, Junfeng Shi, Hongyan Qiu, Chengxia Kan, Yujie Ma, Ningning Hou, Fang Han, Xiaodong Sun · 2024 · Aging Cell
Is carcinoma a mesenchymal disease? The role of the stromal microenvironment in carcinogenesis
Chris Hemmings · 2013 · Pathology
Tackling the tumor microenvironment: what challenge does it pose to anticancer therapies?
Fei Chen, Xinyi Qi, Min Qian, Yue Dai, Yu Sun · 2014 · Protein & Cell
Chemotherapy-Associated Angiogenesis in Neuroblastoma Tumors
Martin Michaelis, Nora Hinsch, U. Ruth Michaelis, Florian Rothweiler, Thorsten Simon, Hans Wilhelm Doerr, Jaroslav Činátl, Jindrich Jr. Cinatl · 2012 · American Journal Of Pathology
Intratumoral heterogeneity and consequences for targeted therapies
Andrei Turtoï, Arnaud Blomme, Vincent Castronovo · 2015 · Bulletin du Cancer
Differential Survival and Therapy Benefit of Patients with Breast Cancer Are Characterized by Distinct Epithelial and Immune Cell Microenvironments
Lennart Kester, Danielle Seinstra, Annelot G.J. van Rossum, Claire Vennin, Marlous Hoogstraat, Daphne van der Velden, Mark Opdam, Erik van Werkhoven, Kerstin Hahn, Iris Nederlof et al. · 2021 · Clinical Cancer Research
Residual Tumor Cells That Drive Disease Relapse after Chemotherapy Do Not Have Enhanced Tumor Initiating Capacity
Ganapati V. Hegde, Cecile de la Cruz, Jeffrey Eastham‐Anderson, Yanyan Zheng, Alejandro Sweet-Cordero, Erica L. Jackson · 2012 · PLoS ONE
Phosphorylation of pericyte FAK-Y861 affects tumour cell apoptosis and tumour blood vessel regression
Delphine M. Lees, Louise E. Reynolds, Ana‐Rita Pedrosa, Marina Roy-Luzarraga, Kairbaan Hodivala‐Dilke · 2021 · Angiogenesis
Stress-induced cellular senescence contributes to chronic inflammation and cancer progression.
KOBASHIGAWA, SHINKO, M. SAKAGUCHI, YOSHIHIKO, MASUNAGA, SHINICHIRO, MORI, EIICHIRO · 2019 · Thermal Medicine
HOTAIR in solid tumors: Emerging mechanisms and clinical strategies
Xiangchen An, Yili Liu · 2022 · Biomedicine & Pharmacotherapy
Trimethylamine N-oxide: role in cell senescence and age-related diseases
Lin Zhang, Fang Yu, Jian Xia · 2022 · European Journal of Nutrition
DNA Damage Induces a Secretory Program in the Quiescent TME that Fosters Adverse Cancer Phenotypes
Luis Gomez-Sarosi, Yu Sun, Ilsa M. Coleman, Daniella Bianchi-Frias, Peter S. Nelson · 2017 · Molecular Cancer Research
A novel STAT3 inhibitor, HJC0152, exerts potent antitumor activity in glioblastoma.
Zhaoqing Li, Tingting Zhu, Yini Xu, Chuanqiang Wu, Jinliang Chen, Yu Ren, Lingping Kong, Shanshan Sun, Wenyu Guo, Yu Wang et al. · 2019 · PubMed Central
Gene expression changes in melanoma metastases in response to high‐dose chemotherapy during isolated limb perfusion
Jasper Wouters, Marguerite Stas, Olivier Govaere, Kathleen Van den Eynde, Hugo E J Vankelecom, Joost J. van den Oord · 2012 · Pigment Cell & Melanoma Research
The innate immune system as mediator of systemic DNA damage responses
Maria Ermolaeva, Björn Schumacher · 2013 · Communicative & Integrative Biology
p38 MAPK inhibits nonsense-mediated RNA decay in response to persistent DNA damage in noncycling cells
Andrew Nickless, Abigael Cheruiyot, Kevin C. Flanagan, David R Piwnica-Worms, Sheila A. Stewart, Zhongsheng You · 2017 · Journal of Biological Chemistry
Small extracellular vesicles deliver TGF‐β1 and promote adriamycin resistance in breast cancer cells
Chunli Tan, Wenbo Sun, Zhi Xu, Shuyi Zhu, Weizi Hu, Xiumei Wang, Yanyan Zhang, Guangqin Zhang, Zibin Wang, Yong Xu et al. · 2021 · Molecular Oncology
The potential role of the thymus in immunotherapies for acute myeloid leukemia
Christopher Hino, Yi Xu, Jeffrey Xiao, David J. Baylink, Mark Evan Reeves, Huynh Le Cao · 2023 · Frontiers in Immunology
Thymus-derived hormonal and cellular control of cancer
Wilson Savino, Ailin Lepletier · 2023 · Frontiers in Endocrinology
Enhancing Chemotherapy by RNA Interference
Shuwen Cao, Chunhao Lin, Shunung Liang, Chee Hwee Tan, Phei Er Saw, Xiaoding Xu · 2020 · BIO Integration
Endothelial Cords Promote Tumor Initial Growth prior to Vascular Function through a Paracrine Mechanism
Chengjian Zhao, Wei jin Zhang, Yuwei Zhao, Yunsheng Yang, Hui Bo Luo, Gaili Ji, Edward Dong, Hongxing Deng, Shuo Lin, Yuquan Wei et al. · 2016 · Scientific Reports
Adipocyte-conditioned medium induces resistance of breast cancer cells to lapatinib
Aline Geneste, Minh Ngoc Duong, L. Molina, Louise Conilh, Sabine Beaumel, Aurore Cleret, Kamel Chettab, Maëlle Lachat, Lars Petter Jordheim, Eva‐Laure Matera et al. · 2020 · BMC Pharmacology and Toxicology
IFNβ1 secreted by breast cancer cells undergoing chemotherapy reprograms stromal fibroblasts to support tumour growth after treatment
Ana Rita R. Maia, Zuguang Gu, André Koch, Mireia Berdiel‐Acer, Rainer D. Will, Matthias Schlesner, Stefan Wiemann · 2021 · Molecular Oncology
The oncoprotein BCL6 enables solid tumor cells to evade genotoxic stress
Yanan Liu, Juanjuan Feng, Kun Yuan, Zhengzhen Wu, Longmiao Hu, Yue Lu, Kun Li, Jiawei Guo, Jing Chen, Chengbin Ma et al. · 2022 · eLife
Immune cell status, cardiorespiratory fitness and body composition among breast cancer survivors and healthy women: a cross sectional study
Ainhoa Arana Echarri, Lauren Struszczak, Mark J. Beresford, John P. Campbell, Robert H. Jones, Dylan Thompson, James E. Turner · 2023 · Frontiers in Physiology
Fibroblast inhibition by tocilizumab enabled gemcitabine/nab‐paclitaxel rechallenge for pancreatic cancer
Shuichi Mitsunaga, Masafumi Ikeda, Hiroshi Imaoka, Mitsuhito Sasaki, Kazuo Watanabe, Akihiro Sato, Kazunori Aoki, Atsushi Ochiai, Mayu Makikawa, Masanobu Nishidate et al. · 2023 · Cancer Science
Live Imaging of Drug Responses in the Tumor Microenvironment in Mouse Models of Breast Cancer
Elizabeth S. Nakasone, Hanne Arenberg Askautrud, Mikala Egeblad · 2013 · Journal of Visualized Experiments
BCL-2 family genetic profiling reveals microenvironment-specific determinants of chemotherapeutic response
Luke A. Gilbert, Corbin E. Meacham, Hai Jiang, Michael T. Hemann, Justin R. Pritchard, Shingleton, Jennifer R., Douglas A. Lauffenburger · 2011 · DSpace@MIT (Massachusetts Institute of Technology)
Putting the brakes on anticancer therapies: suppression of innate immune pathways by tumor-associated myeloid cells
Masahisa Jinushi, Hideo Yagita∥, Hironori Yoshiyama, Hideaki Tahara · 2013 · Trends in Molecular Medicine
15-Deoxy-Δ12,14-prostaglandin J2Induces Apoptosis and Upregulates SOCS3 in Human Thyroid Cancer Cells
Carlos Antônio Trindade‐da‐Silva, Carolina Fernandes Reis, Lara Vecchi, Marcelo Henrique Napimoga, Marcelo Sperandio, Bruna França Matias Colombo, Patrícia Terra Alves, Laura Sterian Ward, Carlos Ueira‐Vieira, Luíz Ricardo Goulart · 2016 · PPAR Research
Tonicity-responsive enhancer-binding protein promotes stemness of liver cancer and cisplatin resistance
Jun Ho Lee, Jae Hee Suh, Hyun Je Kang, Soo Youn Choi, Seok Won Jung, Whaseon Lee‐Kwon, Soo‐Ah Park, Hajin Kim, Byeong Jin Ye, Eun Jin Yoo et al. · 2020 · EBioMedicine
Preclinical studies of 5-fluoro-2′-deoxycytidine and tetrahydrouridine in pediatric brain tumors
Marie Morfouace, Birgit V. Nimmervoll, Nidal Boulos, Yogesh T. Patel, Anang A. Shelat, Burgess B. Freeman, Giles W Robinson, Karen D. Wright, Amar J. Gajjar, Clinton F. Stewart et al. · 2015 · Journal of Neuro-Oncology
Induction of Metastasis by Low-dose Gemcitabine in a Pancreatic Cancer Orthotopic Mouse Model: An Opposite Effect of Chemotherapy
Norihiko Sugisawa, Kentaro Miyake, Takashi Higuchi, Hiromichi Oshiro, ZHIYING ZHANG, Jun Ho Park, Kei Kawaguchi, Sant P. Chawla, Michael Bouvet, Shree Ram Singh et al. · 2019 · Anticancer Research
IL-12 Augments Antitumor Responses to Cycled Chemotherapy
Lingbing Zhang, Dongdong Feng, Yingbin Hu, Kangla Tsung, Jeffrey Allen Norton · 2015 · Journal of Immunotherapy
Anti-Cancer Activity of a Novel Small Molecule Compound That Simultaneously Activates p53 and Inhibits NF-κB Signaling
Sun Gwan Hwang, Jinah Park, Joo Young Park, Cheol Hyoung Park, Ki-Ho Lee, Jeong Woo Cho, Jong‐Ik Hwang, Jae Young Seong · 2012 · PLoS ONE
Prognostic implications of the DNA damage response pathway in glioblastoma
Do‐Hyun Nam · 2011 · Oncology Reports